Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Methylergonovine in Patients Undergoing Cesarean Delivery With Twin Gestations: A Randomized Controlled Trial

NCT05772156 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT05772156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05772156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Methylergonovine in Patients Undergoing Cesarean Delivery With Twin Gestations: A Randomized Controlled Trial
Lead sponsor
Columbia University
Phase
Phase 4
Overall status
Completed
Start date
March 7, 2023
Completion date
March 11, 2024
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

postpartum hemorrhage, twin; complicating pregnancy